Rate My Professor Nigel Stallard

Professor Nigel Stallard is Professor of Medical Statistics and Director of Warwick Clinical Trials Unit at Warwick Medical School, University of Warwick. He earned a first degree in Mathematics from the University of Cambridge and an MSc and PhD in Applied Statistics from the University of Reading, where he worked for ten years before joining Warwick in 2005. At Warwick, he has held positions including Head of the Statistics and Epidemiology Group and Deputy Head of the Division of Health Sciences. Stallard serves as Editor-in-Chief of the journal Statistics in Medicine since 2021. His research centers on the statistical design and analysis of clinical trials, with particular emphasis on optimal trial designs for rare diseases and small populations, as well as methodology for trials involving interim analyses, adaptations such as treatment or subgroup selection, and the use of short-term endpoint data for decision-making.

STALLard has made significant contributions to clinical trial methodology, including coordination of the InSPiRE project on innovative methods for small populations research under the European Commission's Seventh Framework Programme. He has published over 200 peer-reviewed articles in methodological and medical journals, with key works including 'Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges' (2021), 'Efficient Adaptive Designs for Clinical Trials of Interventions With a Rare or Heterogeneous Disease' (2020), 'Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis' (2020, Lancet Neurology), and 'Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome coronavirus 2 pandemic' (2024). His research has influenced trial designs in areas such as multiple sclerosis, COVID-19 respiratory failure, and neonatal seizures, advancing efficient and ethical approaches for challenging patient populations. Stallard has also contributed to editorial boards, workshops, and international collaborations, enhancing the impact of statistical methods in medical research.